🇺🇸 Regranex in United States

2,416 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 676 reports (27.98%)
  2. Wound Complication — 449 reports (18.58%)
  3. Application Site Pain — 313 reports (12.96%)
  4. Drug Ineffective — 199 reports (8.24%)
  5. Inappropriate Schedule Of Drug Administration — 169 reports (7%)
  6. Osteomyelitis — 166 reports (6.87%)
  7. Incorrect Drug Administration Duration — 119 reports (4.93%)
  8. Wound Infection — 117 reports (4.84%)
  9. Toe Amputation — 106 reports (4.39%)
  10. Application Site Erythema — 102 reports (4.22%)

Source database →

Regranex in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Regranex approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Regranex in United States?

Solsys Medical LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.